Close Menu

Chinese Academy of Sciences

In Nature this week: method to uncover genetic components of complex traits, novel cytosine base editor, and more.

In Science this week: genetic history of individuals from northern and southern East Asia, and more.

Ancient sequences from two-dozen individuals revealed genetically distinct populations from northern and southern East Asia that ultimately met and mixed.

In Genome Biology this week: computational approach to determine phylogenetic relationships from single-cell data, metagenomic classification pipeline, and more.

In Genome Biology this week: difference in methylation in neurons from Parkinson's disease patients, differential expression analysis by barcoded sequencing approach, and more.

In Science this week: perspective piece says AI can accelerate drug discovery by using genomic and chemical data, and more.

In Nature this week: epigenetic factors that prevent healthy aging and more.

In Nature this week: review of scientific, technical, and ethical aspects of therapeutic genome editing; fitness consequence map for rice; and more.

In Nature this week: new study of the Wuhan coronavirus suggests bats as the source of the outbreak, bioinformatic approach to identify cancer driver genes, and more.

In PNAS this week: remethylation of DNMT3A in mice affects expansion of myeloid cells, glycan and receptor expression in glioblastoma, and more.

Pages

New analyses indicate female researchers are publishing less during the coronavirus pandemic than male researchers, according to Nature News.

A study suggests people with the ApoE e4 genotype may be more likely to have severe COVID-19 than those with other genotypes, the Guardian says.

Direct-to-consumer genetic testing companies are searching for a genetic reason for why some people, but not others, become gravely ill with COVID-19, the Detroit Free Press reports.

In PNAS this week: forward genetics-base analysis of retinal development, interactions of T cell receptors with neoantigens in colorectal cancer, and more.